(Q44537100)

3 December 2017

title

A short report on clinical evaluation of RIX4414: highlights of world-wide development (English)

1 reference

3 December 2017

6

1 reference

3 December 2017

De Vos B

1

1 reference

3 December 2017

Delem A

2

1 reference

3 December 2017

Hardt K

3

1 reference

3 December 2017

Bock HL

4

1 reference

3 December 2017

Meurice F

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

25 July 2005

1 reference

3 December 2017

1 reference

3 December 2017

volume

24

1 reference

3 December 2017

issue

18

1 reference

3 December 2017

page(s)

3777-3778

1 reference

Global Illness and Deaths Caused by Rotavirus Disease in Children

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.011

Development of candidate rotavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.011

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.011

Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.011

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.011

Rotavirus as a cause of diarrheal morbidity and mortality in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.07.011

1 reference

3 December 2017

1 reference